Yahoo
OTC Markets OTCPK USD

Calithera Biosciences, Inc. (CALA)

0.0001 0.0000 (0.00%)
At close: November 5 at 4:00:00 PM EST
Chart Range Bar
Loading chart for CALA
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0010
  • Volume 315
  • Avg. Volume 203
  • Market Cap (intraday) 487
  • Beta (5Y Monthly) -1.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

www.calithera.com

8

Full Time Employees

December 31

Fiscal Year Ends

Shell Companies

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CALA
0.00%
S&P 500 (^GSPC)
7.42%

1-Year Return

CALA
90.00%
S&P 500 (^GSPC)
8.20%

3-Year Return

CALA
99.67%
S&P 500 (^GSPC)
68.73%

5-Year Return

CALA
100.00%
S&P 500 (^GSPC)
56.54%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY22
Revenue --
Earnings -9.8M
Profit Margin 0.00%

Q4

FY21

Q1

FY22

Q2

FY22

Q3

FY22

-60M
-40M
-20M
0
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -56.29%

  • Return on Equity (ttm)

    -114.14%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -21.29M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.45M

  • Total Debt/Equity (mrq)

    8.17%

  • Levered Free Cash Flow (ttm)

    -28.17M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: